The kinetics of binding of recombinant eglin c to bovine pancreatic chymotrypsin was studied by conventional and stopped-flow techniques. With nanomolar enzyme and inhibitor concentrations, the inhibition was fast and pseudoirreversible (ka,ssoc = 4 x 106 M--s-s at 7.4 and 25°C). Reaction of the enzyme-inhibitor complex with az-proteinase inhibitor, an irreversible chymotrypsin ligand, resulted in a slow release of free eglin c, which was monitored by electrophoresis (kdiSOC 1.6 x 10-6 s-1, t2 -5 days). The proflavin displacement method and a stopped-flow apparatus were used to monitor the association of chymotrypsin with eglin c under a wide range of inhibitor concentration and under pseudo-first-order conditions. At pH 7.4 and 25°C or 5°C, or at pH 5.0 and 25°C, the pseudo-first-order rate constant of proflavin displacement increased linearly with eglin c up to the highest concentration tested, suggesting a one-step bimolecular association reaction: E+I '-,El. However, kassoc is much lower than the rate constant for a bimolecular reaction and its activation energy (66 kJ mol-V at pH 7.4 and 78 kJ mol-1 at pH 5.0) is far too high for a diffusioncontrolled step.
INTRODUCTION
Eglin c, an 8.1 kDa protein, is a serine-proteinase inhibitor first isolated from the leech Hirudo medicinalis [1] and now produced by genetic engineering [2] for therapeutic purposes. Recombinant eglin c is indistinguishable from the natural molecule with respect to its immunological and kinetic properties [3] , although its N-terminal amino acid residue is acetylated. It tightly inhibits neutrophil elastase, neutrophil cathepsin G, pancreatic chymotrypsin and subtilisin, but weakly interacts with trypsin or porcine pancreatic elastase and is inactive on plasmin, thrombin and kallikrein [1] . The kinetic analysis of its interaction with neutrophil elastase indicates that the equilibrium dissociation constant of the complex is 2.7 x 101-2 M [4] . Owing to this high inhibitory potency, eglin c was thought to be a potential drug against inflammation, cystic fibrosis or emphysema, diseases in which neutrophil elastase is involved [5] .
Eglin c shares sequence identities with two chymotrypsin inhibitors from barley (Hordeum vulgare) grains [6] , with potato (Solanum tuberosum) inhibitor I [7] and with two proteinase B inhibitors from yeast (Saccharomyces cerevisiae) [8] . Partial amino-acid-sequence identities established several families of serine-proteinase inhibitors [9] . Eglin c belongs to the potato inhibitor I family characterized by a small number of disulphide bridges. Actually, eglin c has no disulphide bridges at all, and yet it is a remarkably stable protein [3] .
Eglin c in complex with subtilisin Carlsberg is a wedge-shaped disc with the active-site loop at the narrow end of the wedge [10] . This loop encompasses nine amino acid residues with P1 = Leu-45 and P'1 = Asp-46 and its conformation is stabilized by interactions with arginine side chains [11] . The nature of the P1 residue explains why the inhibitor poorly binds trypsin and strongly interacts with chymotrypsin. The inhibition of the latter by eglin c has been studied by Seemuller et al. [1] , who used two substrates with different susceptibilities to chymotrypsin. Both titration curves were linear, indicating good affinity. A precise value for the equilibrium dissociation constant of the complex was, however, not given. Also, association and dissociation rate constants were not measured.
Here we describe the measurement of these parameters as well as stopped-flow experiments aimed at testing whether the stable chymotrypsin-eglin complex is preceded by a loose pre-equilibrium complex as is the case with members of the soybeantrypsin-inhibitor and the pancreatic-trypsin-inhibitor families of proteinase inhibitors [13, 14] .
EXPERIMENTAL Materials
Three-times-crystallized bovine a-chymotrypsin was obtained from Worthington Biochemical Corp, Freehold, NJ, U.S.A., and was active-site-titrated with N-trans-cinnamoylimidazole (Sigma, St. Louis, MO, U.S.A.) as described by Schonbaum et al. [14] . Proflavin was purchased from Mann Research Laboratories, New York, NY, U.S.A. Recombinant eglin c was generously given by Dr. H. P. Schnebli (Ciba-Geigy, Basel, Switzerland) and was active-site-titrated with active-site-titrated chymotrypsin and leucocyte elastase as described previously [4] . Succinyl-Ala2-Pro-Phe p-nitroanilide (Suc-Ala2-Pro-Phe-pNA) [15] and SucAla2-Phe-pNA [16] , two chymotrypsin substrates, were purchased from Bachem, Bubendorf, Switzerland. Human plasma a1-proteinase inhibitor (alPI) was isolated and active-site-titrated as described previously [17] . Throughout the present paper all concentrations of enzyme and inhibitor are given in molarities of active proteins. Most of the kinetic experiments were done in 50 mM-Hepes/100 mM-NaCl, pH 7.4, at 25 'C. Methods Kinetic measurements using proflavin. Most rate constants for the association of chymotrypsin with eglin c were measured using the proflavin-displacement method [13, 18, 19] of the apparatus was about 1 ms. One syringe contained 2 /sMenzyme and the other was filled with inhibitor ,UM) and 60 /LM-proflavin.
The equilibrium dissociation constant (Kp) of the proflavin-chymotrypsin complex was measured by differential spectrophotometry at 465 nm [19, 20] ) using a Cary 2200 spectrophotometer. The measurements were made with constant concentrations of proflavin (2 ,uM) and increasing concentrations of chymotrypsin (20-160 fuM) . Differential spectrophotometry at 465 nm also showed that eglin c displaced proflavin stoichiometrically from its complex with chymotrypsin, indicating that the dye and the inhibitor are competing ligands for the enzyme. Control experiments showed that free or chymotrypsin-bound eglin c did not bind proflavin. The decrease of absorbance at 465 nm could thus be used to monitor the association of eglin c with chymotrypsin.
Kinetic measurements using substrates. Synthetic substrates were also used to assess the kinetics of binding of eglin c to chymotrypsin. In one set of experiments, equimolar concentrations of enzyme and inhibitor (5 nM) were allowed to react for given periods of time before addition of 10 1l of 30 mM-Suc-Ala2-Pro-Phe-pNA (dissolved in NN-dimethylformamide) to 990 ,ul of reaction mixture. In these experiments the substrate measures the residual enzyme activity and stops the association process, since its concentration is 6-fold higher than Km [15] . The residual enzyme activities were measured at 410 nm and 25°C and were used to calculate the concentrations of unchanged enzyme at the time of addition of substrate.
In another set of experiments, the binding of chymotrypsin to eglin c was allowed to proceed in the presence of the less sensitive and more soluble substrate Suc-Ala2-Phe-pNA. The enzyme (0.7 nM) was added to a mixture of 7 nM-inhibitor and 7 mMsubstrate and the release of product (A410) was recorded with a Cary 2200 spectrophotometer on line with an IBM PS/2 model 30 microcomputer.
Dissociation of the chymotrypsin-eglin c complex with acPI. This experiment was done in a buffer containing 50 mM-Hepes, 100 mM-NaCl and 20,uM-NaN3 at pH 7.4 and at 25 In order to detect complex dissociation, we measured the kinetics of enzyme-inhibitor binding in the presence of a substrate. Suc-Ala2-Phe-pNA was used for this purpose because it is more water-soluble and less sensitive than Suc-Ala2-ProPhe-pNA [16] . Hence a very large excess of substrate could be used ([S,] = 67 Kj) and substrate depletion was negligible during the long duration of the experiment (6 h). Enzyme (E) was added to a mixture of inhibitor (I) and substrate (S) and the release of Equimolar amounts of enzyme and inhibitor (5 nM) were mixed and Suc-Ala2-Pro-Phe-pNA (0.3 mm, 6 K.) was added after various periods of time to stop the association process and to measure the residual enzyme activity, which was used to calculate the concentration of free enzyme. The data were plotted in accordance with eqn. (2) . ti was 45 s.
RESULTS

Eglin c as a tight-binding pseudo-irreversible inhibitor of chymotrypsin
The enzyme-inhibitor interaction was first studied using low reactant concentrations in order to measure the overall classical rate constants k.SSOC and kdissoc shown in the progress curve could be described by the following equation [22] :
where P is the product concentration, vo the velocity at t = 0, v. the steady-state velocity and k the apparent first-order rate constant for the approach to the steady state. We used low enzyme and inhibitor concentrations (0.7 nm and 7 nm respectively) together with a high substrate concentration (67 Km) to favour the dissociation of El. Progress curves such as that shown in Fig. 2 
The following constants were found: k.SOC = 4.0 x 106 M-l s-1; kdissoc. 3.6 x 10-fs-6 . The former is in excellent agreement with the value measured above under second-order conditions. The latter must be considered as tentative, because its magnitude is only about 1 % that of k.
To demonstrate clearly the reversibility of the binding and to better estimate kdissoe we used alPI to dissociate the El complex.
The dissociation reaction is summarized in Scheme 3:
alPI E-alPI Scheme 3 alPI is an irreversible and fast-acting inhibitor of chymotrypsin (klSSo = 5.9 x 106 M-1 -s-') [24] which should effectively shift the E+I= 1 El equilibrium. The El complex was allowed to react with alPI, and samples from the mixtures were withdrawn and electrophoresed. Fig. 3(a) shows typical gels run at zero time and after 65 and 136 h of incubation. As can be seen, the bands corresponding to free eglin and to the a,PI-chymotrypsin complex progressively increase in intensity. Densitometry scanning allowed us to estimate the concentration of free inhibitor, which is plotted as a function oftime in Fig. 3(b) . [13] . The typical stopped-flow trace shown in Fig. 4 demonstrates that the decrease in absorbance at 465 nm is indeed first-order. The apparent pseudo-first-order rate constant, kObS derived from such a trace is given by:
k2 [10] (Scheme 4b) higher eglin c concentrations, we used experimental conditions under which the rate of association was supposedly lower. At pH 7.4 and 5°C, kobs again increased linearly with [IO] up to the highest concentration tested (1 mM; see Fig. 5 ). The same was true at pH 5.0 (50 mM-acetate/100 mM-NaCI) and 25 and 5°C kobS was measured as described in Fig. 4 Fig. 7 . pH-dependence of the association rate constant k___. at 25°C as measured by the proflavin-displacement method The following buffers were used: 50 mM-acetate/100 mM-NaCl, pH 5.0 and 5.5; 50 mM-Mes/I00 mM-NaCl, pH 6.0 and 6.5; 50 nMHepes/100 mM-NaCl, pH 7.0 and 7.4; 50 mM-Tris/ 100 mM-NaCl, pH 8.0-9.0. The solid line was calculated with eqn. (9) , whose parameters were determined by non-linear regression analysis. protonated or if one of its basic group is fully deprotonated. The following equation takes into account these assumptions: kassoc. alPI, a fast-acting irreversible chymotrypsin ligand [24] . The slow appearance of free eglin c, as monitored by electrophoresis, allowed a rough estimate of kdissoc to be made (1.6 x 10-6 S-', ti 5 days). The eglin c-chymotrypsin complex is thus extremely stable. K1 t 4.0 x 10-13 M, AGO -70 kJ -mol-1. This tight binding explains why reaction of constant amounts of chymotrypsin with increasing amounts of eglin c yielded straight inhibition curves [1] .
The active-site loop of eglin c encompasses nine amino acid residues, with P1 being Leu-45 and P'1 being Asp-46 [11] . That P1
is occupied by a leucine residue accounts for the poor binding of eglin c with trypsin and trypsin-like enzymes from the coagulation and kinin systems [1] and the very strong binding of bovine pancreatic chymotrypsin, an enzyme that rapidly hydrolyses substrates with P1 = Leu. Human pancreatic elastase, another member of the chymotrypsin family, binds less tightly to eglin c than chymotrypsin (k assoc-=7. This Scheme predicts that dissociation of C by an agent that traps E leads to a mixture of I and I*. In our case I* would be eglin c with the Leu-45-Asp-46 peptide bond broken. The trapping agent used in the current study was acPI, and the release of eglin c was monitored by electrophoresis. Since the inhibitor has no disulphide bonds [11] , I* should migrate as two lowmolecular-mass peptides with different charges. Such a pattern was not observed on the various electrophoregrams. Trace amounts of I* would ofcourse not be detected by electrophoresis, the more so in that we followed the dissociation reaction only to about 40 % competition. We may nevertheless conclude that the C = X L* B E + I* pathway is not significant in our case. This view is supported by the observation that the Leu-45-Asp-46 peptide bond is intact within the eglin c-subtilisin complex [11] .
Also, for enzyme-inhibitor systems that obey the standard mechanism, the [I*]/[I] ratio at equilibrium is very low at neutral pH [9] . The [27] . Secondly, the activation energy for the association process at pH 7.4 (66 kJ mol-') or at pH 5.0 (78 kJ mol-V) is much higher than that for a diffusion-controlled step [28] . The literatures describes enzyme-inhibitor systems which follow the E+I EI* El mechanism while having activation energies for association of 44 kJ mol-V [29] with k ,/kl = Ki* > 5 x 10-4M, k2 > 2 x 103 s-1, k_2 = kdissoc. A striking feature of the eglin c-chymotrypsin association is the very mild effect of pH on k,,,o, which varies by less than 50 % below and above neutral pH. To the best of our knowledge, this is the first proteinase-inhibitor system for which k.s.c is almost independent of pH. The chymotrypsin-pancreatictrypsin-inhibitor pair associates about 100-fold faster at pH 7.0 than at pH 5.0 and the sigmoidal variation of k.soc. with pH is described by a titration curve with a PKa of 7.0 attributable to the ionization of His-57 of the enzyme's active centre [13] . Similar sigmoidal-shaped titration curves have been reported for other systems, k.,O, being at least 5-fold higher at neutral pH than at pH [4] [5] [30, 34] . For other systems, the pH-dependency of k.8Oc.
was a bell-shaped titration curve involving an unprotonated acid and a protonated base of the enzyme in the interaction [29, 31, 35] . More remarkable is the observation that human pancreatic elastase, another chymotrypsin-like enzyme, associates with eglin c with a k.,,aO that increases 6-fold between pH 5.0 and 8.0 [21] .
In an attempt to rationalize the data obtained with the eglin-chymotrypsin system, we have assumed that one partner, i.e. eglin c, is active for association whatever its state of ionization, whereas the other is about 45 % active if an acidic group of PKa 6.3 is fully protonated or if a base with pK, of 8.1 is fully deprotonated. With these assumptions, the bell-shaped pHdependency curve could be fitted to the model outlined in eqn. (8) . The pKa of 6.3 might correspond to His-57 of chymotrypsin, whose deprotonation activates the enzyme's catalytic triad. The PKa of 8.1 is more difficult to rationalize as it is at least one unit lower than the pKa of the N-terminal a-NH2 group of the enzyme which controls the conformation of the active site [36] . We are not unaware that the present model is purely empirical and that others might be suggested.
